Skip to main content

Guardian Unlimited
Go to:  
Guardian UnlimitedThe Guardian
Home UK Business Online World dispatch The Wrap Newsblog Talk Search
The Guardian World News guide Arts Special reports Columnists Audio Help Quiz

UK news
 
  Search this site






  In this section
Fertility clinic planned for lesbian couples

Naked pictures force closure of gallery

Equitable directors snub report

PCs: the latest waste mountain

Shadow cast over boom in online betting

OS maps out the future

Footballers to be told charges they face

Test could cut exam stress for 7-year-olds

Art masterpieces raise 61m at auction

Muslims fear backlash

Channel 4 looks at takeover of Radio 1

Keep power and sewage plants secret, media told

Mobiles to let parents keep a track on children

Visionary or fortune teller? Why scientists find diagnoses of 'x-ray' girl hard to stomach

Five may face trial over killing of sergeant in Iraq body armour case

Dyke ally appointed head of Radio 4

25% of Asian football fans face racism

Rural bus services threatened by funding reform

Birth of hope for women with cancer

Liverpool religious leaders unite in prayers for hostage

Dating website for canines (and possibly their owners)

Yacht pilot cleared of beach death

Law Society to hive off regulation

Reporter in palace breach

Davies says Hutton was myopic

Yusuf Islam consults lawyers

Final test for sport's forgotten winners

Sinead begs for mercy after nits joke

Now the fug of smoke has lifted, all eyes are on Dublin

Hospitals to bill firms for works accidents

Police chairman attacks child sex abuse smear

Boy shot in head while walking dog

In brief


Seroxat and Prozac 'can make people homicidal'

Doctor who found suicide risk says experts ignoring danger

Sarah Boseley, health editor
Tuesday September 21, 2004
The Guardian


Evidence that antidepressant drugs like Seroxat and Prozac could make people homicidal is being ignored by the body responsible for regulating medicines in the UK, a leading expert said yesterday.

The charge came from David Healy, an expert on psychiatric drugs from north Wales whose warnings that the drugs could cause suicide prompted a major inquiry. That investigation, by an expert working group of the Medicines and Healthcare Products Regulatory Authority, led to the entire class of drugs except Prozac being banned last year from use in children.

The expert working group has gone on to look at suicides in adults taking any of the drugs known as SSRIs (selective serotonin reuptake inhibitors). But Dr Healy says that they are overlooking very important data relating to a set of further dangerous side-effects.

Dr Healy, director of the north Wales department of psychological medicine, says he has seen data from the clinical trials that show even some healthy volunteers - people with no illness at all volunteering to take part in the earliest safety trials of the drugs - became unaccountably aggressive. Their reaction is coded as "hostile" which can include homicidal behaviour and serious aggression.

"I think there is very clear evidence for all of the SSRI group of drugs that in addition to making people suicidal, they can make people homicidal or seriously aggressive and the data have been sitting in the MHRA's files on this issue," he said.

"It is there for children across a range of different problems, it is there for healthy volunteers and a range of adults and the MHRA has paid no heed to this."

The healthy volunteer trials of the British drug Seroxat took place in the late 1980s or early 1990s. Of the 271 fit and well individuals, three became hostile, compared with none on an inactive placebo - a rate of 1.1%, which although small could translate to very many cases among the 50m worldwide who have taken Seroxat over the last 15 years.

The signal from the healthy volunteer trials is supported by data from trials in children on Seroxat for obsessive compulsive disorder (OCD), depression and social phobia. Children taking part amounted to 738 on Seroxat and 647 on placebo. Of those, there were 27 hostile events on Seroxat and only four on placebo. Taking the children with OCD alone, those on the drug were 17 times more likely to become aggressive than those on placebo.

Trials of Seroxat (known generically as paroxetine) for women with pre-menstrual syndrome show a similar pattern, with five hostile acts on the drug and none on placebo.

But, says Dr Healy, the MHRA officials appear not to have picked up the signals from all the separate trials and are failing to see the whole picture.

A number of cases where people have argued their aggressive acts were due to one of the SSRI antidepressants have come to court. In the most dramatic, a US jury in 2001 found that GlaxoSmithKline's drug was partly responsible for the murders committed by Donald Schell. After two days on Paxil (as Seroxat is named in the USA), Schell killed his wife, his daughter and his baby granddaughter before shooting himself dead. GlaxoSmithKline was ordered to pay $8m (4.5m) to the remaining family members.

GlaxoSmithKline last night denied that its drug caused adults to become hostile, although it acknowledged there had been a problem in the children's trials. "There is no compelling evidence from our clinical trials that Seroxat causes hostile behaviour in adults. When you put the results from all the clinical trials together there is no difference between the rates of hostility for adult patients taking Seroxat and the patients taking placebo, or dummy pill. This data has been shared with regulators including the MHRA," said a spokesman.

The MHRA said yesterday that the working group had looked at the data on events coded as "hostility" in its analysis of the children's trials and that it had acted to prevent the use of most SSRIs in children as a result of all the data, including that on hostility. "The review of adult data is ongoing," it said.


Be in the know
Sign up for our email bulletins

Related articles
19.06.2004: Glaxo changes tack after Spitzer assault
03.06.2004: Glaxo faces drug fraud lawsuit
14.06.2004: Safety alert on adult use of antidepressants
23.04.2004: SSRI dangers for children 'suppressed'

Big issues
Mental health

Glossary
A-Z guide to public services and voluntary sector speak

Useful sites
European Agency for the Evaluation of Medicinal Products
Medicines and Healthcare Regulatory Agency
Mind
GlaxoSmithKline
The medicines and healthcare products regulatory agency
Department of Health: mental health
Depression Alliance
The Royal College of Psychiatrists
Institute of Psychiatry




Printable version | Send it to a friend | Save story

 
 



UP

Guardian Unlimited Guardian Newspapers Limited 2004